In 2010, asthma accounted for 3,404 deaths, 439,000 hospitalizations, 1.8 million emergency department (ED) visits, and 14.2 million physician office visits.
The estimated total cost of asthma to society, including medical expenses was $50.1 billion per year.
Asthma morbidity and mortality continue to be a major public health concern in our nation. Evidence based approaches that help avert ED visits and hospitalizations are well documented. The StellarRx distribution model facilitates selected evidence-based approaches such as increasing access to essential controller and rescue medications at the point of care free of charge to the clinician and patient.
Starting patients on life saving asthma medications on site, allows for clinician-patient-family dialogue and instructional support; a well recognized evidence-based practice. Stellar RX™ also provides patients with refill and medical visit reminders to help them remain adherent to their overall asthma action plan.